DOCSLIB.ORG

The 20Th Annual Norman P. Salzman Memorial Award and Symposium in Virology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The 20Th Annual Norman P. Salzman Memorial Award and Symposium in Virology Presents The 20th Annual Norman P. Salzman Memorial Award and Symposium in Virology Monday, November 5, 2018 The Warren Grant Magnuson Clinical Center Lipsett Auditorium National Institutes of Health Norman P. Salzman, Ph.D. Dr. Norman P. Salzman was a noted pioneer in the field of molecular virology and a founding editor of the Journal of Virology. In 1967 Dr. Salzman became Chief of the Laboratory of Biology of Viruses at the National Institute of Allergy and Infectious Diseases (NIAID) where he encouraged independence and excellence among his Fellows. Upon his retirement from NIH in 1986, Dr. Salzman moved to Georgetown University to head the Laboratory of Molecular Retrovirology, where he began his research on AIDS. This important work continued after he moved his laboratory in 1994 to the Frederick Cancer and Development Center (SAIC Program), where Dr. Salzman was appointed Director of an innovative mentoring program for post- doctoral fellows. Dr. Salzman was among the first to characterize viral mRNAs and to visualize replicating viral DNA. During his distinguished career at NIH, Dr. Salzman made many important and innovative contributions to our basic understanding of the replication of poliovirus, vaccinia virus, polyoma virus, SV40 virus and BK virus. Dr. Salzman’s studies on human immunodeficiency virus led to his discovery that ongoing evolution of viral quasi-species, despite combination antiretroviral therapy, characterized the relationship among viruses from different compartments and elucidated novel mechanisms of antiretroviral drug resistance. This work set the stage for todays’ work focusing on the role of viral reservoirs and challenges to HIV cure. Dr. Salzman’s memorable achievements in virology are paralleled by the recognition that his laboratory was a training ground for many young scientists, several of whom went on to become laboratory or section Chiefs at the NIH, and others to hold leadership positions in academia and industry all over the world. Six have been elected to the National Academy of Sciences and one received the Nobel Prize. - H. Clifford Lane, M.D., NIAID The Norman P. Salzman Memorial Award and Twentieth Annual Symposium in Virology 9:00 – 9:05 AM Welcome Eric O. Freed, Ph.D., NCI Frederick, NIH 9:05 – 9:15 AM Tribute to Dr. Norman P. Salzman Peter M. Howley, M.D., Dept. of Microbiology and Immunobiology, Harvard Medical School 9:15 – 9:55 AM Keynote Presentation HPV and Cancer: Searching for a Targeted Therapy Peter Howley, M.D., Dept. of Microbiology and Immunobiology, Harvard Medical School 9:55 – 10:25 AM The Potential of International Collaborations for HIV Prevention: Studies of Mother-Infant HIV Transmission Julie Overbaugh, Ph.D., Fred Hutchinson Cancer Research Center 10:25 – 10:40 AM Coffee Break and Poster Presentation 10:40 – 10:50 AM Appreciation Award to the Foundation for the NIH, Maria C. Freire, Ph.D., President and Executive Director, Lenore Salzman 10:50 – 11:00 AM Presentation of the 2018 Norman P. Salzman Memorial Award in Virology Lenore Salzman 11:00 – 11:20 AM Award Lecture Vesicle-Cloaked Virus Clusters are the Optimal Units for Inter-Organismal Viral Transmission Marianita Santiana, Ph.D., Laboratory of Host-Pathogen Dynamics, National Heart Lung and Blood Institute, NIH 11:20 – 11:50 AM Koch’s Postulates in the Age of Viral Metagenomics Eric L. Delwart, Ph.D., Department of Pathology & Laboratory Medicine, University of California, San Francisco 11:50 – 12:20 PM Single-Cell virology Craig E. Cameron, Ph.D., Department of Biochemistry and Molecular Biology, The Pennsylvania State University 12:20 – 12:30 PM Closing Remarks Arifa S. Khan, Ph.D., CBER, FDA 12:30 – 1:30 PM Luncheon at FAES Terrace and Poster Presentation The 2018 Norman P. Salzman Memorial Award in Virology Dr. Marianita Santiana, Laboratory of Host-Pathogen Dynamics, NHLBI Dr Santiana received her B.A. degree in Biology from Rutgers University in Newark, New Jersey and her M. Sc. and Ph.D. in Cellular and Molecular Biology from Rutgers Graduate School in Newark, New Jersey. Her Ph.D. thesis research was carried out at the National Institutes of Health, as part of the NIH Graduate Partnership Program, under the supervision of Dr. Nihal Altan-Bonnet. Dr. Santina’s Ph.D. thesis research focused on understanding the dynamics of cellular cholesterol redistribution from the plasma membrane to viral replication organelles during enteroviral infection, and the importance of cholesterol for enteroviral replication. After receiving her Ph.D. degree in 2015, she continued studying host-pathogen dynamics, and her present work focuses on the non-lytic release and transmission of enteric RNA viruses. Poster Presentation Awardees Dissecting Hepatitis B Virus-Host Interactions Fellow: Yuchen Xia, Ph.D. Mentor: T. Jake Liang, M.D. Liver Diseases Virology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases Quaternary Contact in the Initial Interaction of CD4 with the HIV-1 Envelope Trimer Fellow: Qingbo Liu, Ph.D. Mentor: Paolo Lusso, M.D., Ph.D. Viral Pathogenesis Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases HPV Integration Hijacks and Multimerizes a Cellular Enhancer to Generate a Viral-Cellular Super-Enhancer That Drives High Viral Oncogene Express Fellow: Alix Warburton, Ph.D. Mentor: Alison McBride Ph.D. DNA Tumor Virus Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases The 2018 Norman P. Salzman Memorial Mentor Award in Virology Nihal Altan-Bonnet, Ph.D. Senior Investigator, Laboratory of Host-Pathogen Dynamics, National Heart Lung and Blood Institute (NHLBI) Dr. Nihal Altan-Bonnet received her PhD from The Rockefeller University and completed her post-doctoral studies at the National Institutes of Health in the laboratory of Dr. Jennifer Lippincott Schwartz. During both her PhD and post-doctoral investigations, Dr. Altan-Bonnet has focused on applying cutting edge cellular imaging techniques to understanding the dynamic workings of cells, including investigations into pH regulation, membrane trafficking and cell cycle transitions. In 2006 Dr. Altan-Bonnet was appointed Assistant Professor at Rutgers University where she applied her expertise in imaging to understanding the dramatic membrane remodeling events that take place within cells upon infection with Poliovirus, Rhinovirus and Hepatitis C virus. These and other RNA viruses, remodel host intracellular membranes in order to generate new organelles, which they subsequently use as platforms for replication and assembly reactions. Dr Altan-Bonnet investigated the mechanisms by which these organelles were generated and discovered that multiple different RNA viruses rely on the same lipid components to be present in these organelles for replication. These studies have led to the development of new classes of therapeutics centered on the idea of blocking the replication of multiple different viruses by targeting the production of these lipids. In 2013 Dr. Altan-Bonnet moved to the National Institutes of Health as an Earl Stadtman Investigator and Head of the Laboratory of Host-Pathogen Dynamics. In 2017 Dr. Altan-Bonnet became tenured and promoted to Senior Investigator. Dr. Altan- Bonnet has continued to do pioneering research into the virus-host interface and with her group recently discovered a new form of viral transmission among humans and animals whereby viruses enhance their virulence by transporting themselves in clusters inside vesicles. Dr. Altan-Bonnet has been recognized several times for her outstanding research, receiving the Young Investigator Award from the Theobald Smith Society of the American Society for Microbiology in 2011, and the Presidential Early Career Award in Science and Engineering (PECASE) in 2012. Dr. Altan-Bonnet was also appointed as a Kavli Fellow (2013) and a Scialog Fellow (2015-2017). Past Recipients Norman P. Salzman Memorial Award in Virology 1999 Joanna Shisler, NIAID* 2000 Herman Edskes, NIDDK* 2001 Alonzo Garcia, NIAID* 2002 Sonja Best, NIAID, Rocky Mountain Laboratories 2003 Kay Grünewald, NIAMS 2004 Jason Brenchley, NIAID 2005 Yamina Bennasser, NIAID 2006 Christopher Buck, NCI 2007 Adriano Boasso, NCI with Special Recognition of Audray Harris, NIAMS 2008 Alberto Bartesaghi, NCI 2009 Yu Liang, NIAID 2010 Silvia Kang, NINDS 2011 Tobias Paprotka, NCI 2012 Jason McLellan, VRC, NIAID 2013 Rachael M. Schowalter, NCI 2014 Darryl Falzarano, NIAID, Rocky Mountain Laboratories 2015 Christina Guzzo, NIAID*; Elisavet Serti, NIDDK 2016 Ashley Moseman, NINDS 2017 David Angeletti, NIAID; Tuoqi Wu, NHGRI Norman P. Salzman Memorial Mentor Award in Virology 1999 Bernard Moss, NIAID 2000 Reed Wickner, NIDDK 2001 Bernard Moss, NIAID 2002 Marshall Bloom, NIAID, Rocky Mountain Laboratories 2003 Alasdair Steven, NIAMS 2004 Daniel Douek, NIAID 2005 Kuan-Teh Jeang, NIAID 2006 Douglas Lowy, NCI and John Schiller, NCI 2007 Gene M. Shearer, NCI with Special Recognition of Alasdair C. Steven, NIAMS 2008 Sriram Subramaniam, NCI 2009 Thomas Kristie, NIAID 2010 Dorian McGavern, NINDS 2011 Vinay K. Pathak, NCI 2012 Peter Kwong, VRC, NIAID 2013 Chris Buck, NCI 2014 Heinz Feldmann, NIAID, Rocky Mountain Laboratories 2015 Paolo Lusso, NIAID; Barbara Rehermann, NIDDK 2016 Dorian McGavern, NINDS 2017 Jon Yewdell, NIAID; Pamela Schwartzberg, NHGRI Honoring Past Awardees Comments on Their Research “I think I was the first Norman Salzman award winner, and I was a post-doc in Bernie Moss' lab when I won the award.
Load more

Recommended publications
  • Construction and Characterization of an Infectious Vaccinia Virus And
    Proc. Nat. Acad Sci. USA Vol. 80, pp. 7155-7159, December 1983 Biochemistry Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters (hybrid vaccinia virus/chimeric gene/live virus vaccine/recombinant DNA) GEOFFREY L. SMITH*, BRIAN R. MURPHYt, AND BERNARD MOSS* *Laboratory of Biology of Viruses and tLaboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20205 Communicated by Robert M. Chanock, August 29, 1983 ABSTRACT A DNA copy of the influenza virus hemagglu- striction sites for the insertion of the foreign gene segment (6, tinin gene, derived from influenza virus A/Jap/305/57 (H2N2) 7). was inserted into the genome of vaccinia virus under the control In this communication, we describe the formation and prop- of an early vaccinia virus promoter. Tissue culture cells infected erties of a vaccinia virus recombinant that contains the influ- with the purified recombinant virus synthesized influenza hem- enza virus gene for hemagglutinin (HA). The HA genes from agglutinin, which was glycosylated and transported to the cell sur- several influenza subtypes have been cloned and their se- face where it could' be cleaved with trypsin into HAI and HA2 quences determined (14-18), and some of these been ex- subunits. Rabbits and hamsters inoculated intradermally with re- have combinant virus produced circulating antibodies that inhibited pressed in simian virus 40 (SV40) virus vectors (19-22). The hemagglutination by influenza virus. Furthermore, vaccinated product-of this gene is probably the most thoroughly studied hamsters achieved levels of antibody similar to those obtained upon integral membrane protein: its three-dimensional structure has primary infection with influenza virus and were protected against been determined (23), antigenic sites have been mapped (24), respiratory infection with the A/Jap/305/57 influenza virus.
    [Show full text]
  • Replication of Picornaviruses I
    JouRNAL oF VnoLoGy, Dec. 1975, p. 1512-1527 Vol. 16, No. 6 Copyright ©) 1975 American Society for Microbiology Printed in U.SA. Replication of Picornaviruses I. Evidence from In Vitro RNA Synthesis that Poly(A) of the Poliovirus Genome is Genetically Coded KAROLINE DORSCH-HASLER, YOSHIAKI YOGO,' AND ECKARD WIMMER* Department ofMicrobiology, St. Louis University School ofMedicine, St. Louis, Missouri 63104, and Department ofMicrobiology, School ofBasic Health Sciences, State University ofNew York at Stony Brook, Stony Brook, New York 11794 * Received for publication 3 July 1975 A crude replication complex has been isolated from poliovirus-infected HeLa cells and used for synthesis of poliovirus replicative intermediate (RI) RNA, replicative form (RF) RNA, and single-stranded (SS) RNA in vitro. All three classes of virus-specific RNA synthesized in vitro are shown to contain poly(A). Poly(A) of RF and of SS RNA [RF-poly(A) and SS-poly(A)] has a chain length (50 to 70 nucleotides) that is shorter than that of poly(A) of in vivo-synthesized RNAs. Poly(A) of RI [RI-poly(A)], however, is at least 200 nucleotides long and, therefore, larger than poly(A) of RI isolated from HeLa cells 4 h after infection. The crude membrane-bound replication complex contains a terminal adenylate transferase activity that is stimulated by Mn2+ and the addition of an (Ap),AoH primer. This transferase activity is found also in extracts of mock-infected cells. Partial purification of the replication complex in a stepwise sucrose gradient, in which the viral replicase is associated with the smooth cytoplasmic membrane fraction, does not remove the terminal transferase.
    [Show full text]
  • Abstract Book (Pdf)
    6th EMBO/EMBL Conference on Science and Society Science and Security 28 – 29 October 2005 at the European Molecular Biology Laboratory Heidelberg, Germany Organising Committee: Andrew Moore (EMBO, Chair), Halldòr Stefànsson (EMBL), Alessandra Bendiscioli (EMBO), Frank Gannon (EMBO), Iain Mattaj (EMBL) Welcome message n September this year, plans for a new bio-defence laboratory in Montana, USA, were Iunveiled. In the $66.5 million facility, researchers will apply similar scientific knowledge to that which makes bio-terrorism or biological warfare a possibility in the first place. The double-edged sword of science application can hardly be more evident. How successfully can we prevent the misuse of research findings that otherwise give us important insights into the workings of nature and prospects of useful applications? What would be the consequences of tackling this problem by constraining research, the mobility of researchers and the funding and publication of their research? Could we, indeed, ever successfully define “research that should not be done”? How much thought should scientists give to the downstream consequences of their work when deciding what to research, or which experiments to do? In June this year, the USA announced that it would delay the introduction of compulsory biometric passports for travellers from 27 countries in Europe and the Asia-Pacific region until October 2006. But whenever they appear, biometric passports will be part of normal life in the future. In the era of international terrorism, this could, indeed, lead to a safer world; an example of a beneficial use of science. On the other hand, it increases the perception by normal citizens that they are being unnecessarily “watched” by an all- seeing, all-controlling state – the so-called Big Brother of Orwell’s 1984.
    [Show full text]
  • “Let There Be Life”
    Focus: Brave New World “We have reason to believe that the disease is created by a man-made super pathogen...” AND MAN SAID, “LETa short story THERE BE LIFE” By Lawrence Valverde e have reason to believe the nearly 200 scientists simmered with “Wdisease is caused by a man- mumbled comments. The researcher made super-pathogen. The construc- whose speech had been interrupted tion seems to be loosely based on the straightened himself and raised his smallpox virus, but with significant voice in response. modifications, including genes encod- “I hear your concern, Dr. Boots, ing immune system antagonists. It but we have not confirmed whether or also seems to have been specifically not this is, in fact, a terrorist act…” engineered to resist known antivi- “Who else would do such a thing, ral…” Dr. Cervantes?” Dr. Boots demanded. “What do you mean specifically “It wasn’t necessarily done on engineered!” boomed an overweight purpose…” said Dr. Cervantes—the man as he hauled himself out of speaker—but he was interrupted by his chair. “Are you proposing that the clamor that erupted as scientists terrorists may have the technology jump up from their seats. Dr. Cervantes to synthetically create their own vi- frowned. Trying to speak over the ruses?” The surrounding panel of crowd was clearly a lost cause. When credit: Clipart courtesy FCIT. http://etc.usf.edu/clipart credit: Clipart courtesy FCIT. fall 2008 • Harvard Science Review 9 valverde.indd 9 2/9/2009 11:24:54 PM Focus: Brave New World did this whole business with artificially Dr. Boots sputtered.
    [Show full text]
  • Vaccinia Virus and Poxvirology M E T H O D S I N M O L E C U L a R B I O L O G Y™
    METHODS IN MOLECULAR BIOLOGY BIOLOGYTMTM Volume 269 VVacciniaaccinia VirusVirus andand PoxvirologyPoxvirology MethodsMethods andand ProtocolsProtocols Edited by Stuart N. Isaacs Vaccinia Virus and Poxvirology M E T H O D S I N M O L E C U L A R B I O L O G Y™ John M. Walker, SERIES EDITOR 291. Molecular Toxicology Protocols, edited by 270. Parasite Genomics Protocols, edited by Sara Phouthone Keohavong and Stephen G. Grant, E. Melville, 2004 2005 269. Vaccina Virus and Poxvirology: Methods 290. Basic Cell Culture, Third Edition, edited by and Protocols,edited by Stuart N. Isaacs, 2004 Cheryl D. Helgason and Cindy Miller, 2005 268. Public Health Microbiology: Methods and Protocols, edited by John F. T. Spencer and 289. Epidermal Cells, Methods and Applications, Alicia L. Ragout de Spencer, 2004 edited by Kursad Turksen, 2004 267. Recombinant Gene Expression: Reviews and 288. Oligonucleotide Synthesis, Methods and Appli- Protocols, Second Edition, edited by Paulina cations, edited by Piet Herdewijn, 2004 Balbas and Argelia Johnson, 2004 287. Epigenetics Protocols, edited by Trygve O. 266. Genomics, Proteomics, and Clinical Tollefsbol, 2004 Bacteriology: Methods and Reviews, edited 286. Transgenic Plants: Methods and Protocols, by Neil Woodford and Alan Johnson, 2004 edited by Leandro Peña, 2004 265. RNA Interference, Editing, and 285. Cell Cycle Control and Dysregulation Modification: Methods and Protocols, edited Protocols: Cyclins, Cyclin-Dependent Kinases, by Jonatha M. Gott, 2004 and Other Factors, edited by Antonio Giordano 264. Protein Arrays: Methods and Protocols, and Gaetano Romano, 2004 edited by Eric Fung, 2004 284. Signal Transduction Protocols, Second Edition, 263. Flow Cytometry, Second Edition, edited by edited by Robert C.
    [Show full text]
  • Profile of Eckard Wimmer
    PROFILE Profile of Eckard Wimmer he finding caused an uproar. vitalism—the belief that chemicals in liv- Researchers at Stony Brook Uni- ing systems are somehow distinct from Tversity in New York had engi- the chemicals in inorganic systems, such neered poliovirus in a test tube as salt and rocks. That notion was shat- (1). The discovery, led by Eckard Wimmer, tered in 1828, when German chemist elected in 2012 to the National Academy Friedrich Wöhler synthesized the organic of Sciences, dispelled the belief that compound urea from inorganic pre- viruses require a live host to grow cursors (5). and spread. By the 1940s, theoretical physicists and The thought of synthetic viruses terrified biochemists had begun to wonder about an American public still reeling from 9/11 what constitutes life. Wimmer was en- and the subsequent anthrax attacks. What thralled. Biochemistry squared perfectly if the technology to engineer viruses with his worldview, the idea that something wound up in the hands of bioterrorists? as seemingly profound as life could be pared However, today, just a decade later, it is down to its simplest—chemical—form. widely accepted that the ability to engineer While completing his second post- viruses also allows researchers to develop doctoral fellowship at the University of viruses that work as synthetic vaccines, British Columbia in Vancouver in the to carry genetic material into a cell for use mid-1960s, Wimmer attended a talk on in gene therapies, or to preferentially viruses and had his eureka moment. “It attack cancer cells (2). was clear, even though it wasn’t men- Wimmer says his motivations for engi- tioned in that talk, that if viruses can be neering polio were strictly scientific.
    [Show full text]
  • Bert Lawrence Semler
    Curriculum Vitae: Bert Lawrence Semler Contact Information Department of Microbiology and Molecular Genetics School of Medicine, Med Sci B237 University of California Irvine, CA 92697 USA E-mail: [email protected] Phone: (949) 824-7573 FAX: (949) 824-2694 Education 1970-1974 University of California, Irvine Bachelor of Science - Biological Sciences 1974-1979 University of California, San Diego Doctor of Philosophy - Biology Research and Professional Experience 1972-1974 Undergraduate research with Professor H. W. Moore Department of Chemistry, University of California, Irvine 1975-1979 Graduate student with Professor John J. Holland Department of Biology, University of California, San Diego 1979-1983 Postdoctoral fellow with Professor Eckard Wimmer, Department of Microbiology, State University of New York at Stony Brook 1983-1987 Assistant Professor, Department of Microbiology and Molecular Genetics College of Medicine, University of California, Irvine 1987-1991 Associate Professor, Department of Microbiology and Molecular Genetics College of Medicine, University of California, Irvine 1991-2018 Professor, Department of Microbiology and Molecular Genetics School of Medicine, University of California, Irvine 1996-2006 Chair, Department of Microbiology and Molecular Genetics School of Medicine, University of California, Irvine 2000-2010 Associate Director, Center for Virus Research University of California, Irvine 2010-present Director, Center for Virus Research University of California, Irvine 2018-present Distinguished Professor, Department
    [Show full text]
  • Poxvirus DNA Replication
    Downloaded from http://cshperspectives.cshlp.org/ on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press Poxvirus DNA Replication Bernard Moss Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892 Correspondence: [email protected] Poxviruses are large, enveloped viruses that replicate in the cytoplasm and encode proteins for DNA replication and gene expression. Hairpin ends link the two strands of the linear, double-stranded DNA genome. Viral proteins involved in DNA synthesis include a 117-kDa polymerase, a helicase–primase, a uracil DNA glycosylase, a processivity factor, a single- stranded DNA-binding protein, a protein kinase, and a DNA ligase. A viral FEN1 family protein participates in double-strand break repair. The DNA is replicated as long conca- temers that are resolved by a viral Holliday junction endonuclease. oxviruses are large, enveloped, DNA viruses (Moss 2007). The DNA replication proteins, in Pthat infect vertebrate and invertebrate spe- contrast to those involved in early transcription, cies and replicate entirely in the cytoplasm are not packaged in virions but are translated (Moss 2007). Two poxviruses are human-spe- from viral early mRNAs. DNA replication oc- cific: variola virus and molluscum contagiosum curs following release of the genome from the virus. The former causes smallpox, a severe dis- core, and progeny DNA serves as the template ease with high mortality that was eradicated for transcription of intermediate- and late-stage more than two decades ago; the latter is distrib- genes (Yang et al. 2011). uted worldwide and produces discrete benign skin lesions in infants and extensive disease in immunocompromised individuals.
    [Show full text]
  • NAT265 NEW Mx
    news Poliovirus advance sparks fears of data curbs Erika Check, Washington The recent laboratory synthesis of an infec- tious poliovirus is prompting fears among SCIENCE US biologists that the publication of results GETTY IMAGES deemed potentially useful to terrorists may be restricted. The virus was synthesized by a team led by virologist Eckard Wimmer at the State University of New York at Stony Brook. The results, published online by Science on 11 July (J. Cello, A. V. Paul & E. Wimmer Science 10.1126/science.1072266), sparked media reports worldwide suggesting that similar techniques might be used by terrorists to synthesize the Ebola virus or even smallpox. For Eckard Wimmer, his results brought a ‘scary Culture shock: researchers have synthesized this Geneticists fear that the report — the first realization’ that viruses can be recreated. infectious poliovirus in the laboratory. demonstration that a published genome can be turned into an infectious virus — will been used to demonstrate the technique. sequence information. He claims that the encourage calls for a clampdown on the open Wimmer defends his group’s decision to latest research proves that the world can publication of gene sequences of viruses. publish, saying that they are only pointing never stop vaccinating against polio. “You US government officials have been floating out the fact that terrorists could misuse cannot eliminate a virus from existence,” he the idea of such restrictions since the terror- published data. “We’ve been criticized for says. “Somebody can always resynthesize it, ist attacks last autumn (see Nature 414, playing into the hands of a bioterrorist, but and that’s a scary realization.” 237–238; 2001).
    [Show full text]
  • Moss, Bernard 2018 Dr
    Moss, Bernard 2018 Dr. Bernard Moss Oral History Download the PDF: Moss_Bernard_oral_history (155 kB) This is an interview with Dr Bernard Moss on June 25th, 2018, at the National Institutes of Health (NIH) about his career in the National Institute of Allergy and Infectious Diseases (NIAID). The interviewer is Dr. Victoria Harden, the Founding Director, Emerita, of the Office of NIH History and Stetten Museum. Harden: Dr Moss, would you state your name, and that you're aware that this is being recorded, and that you give permission for the recording? Moss: My name is Bernard Moss, and I'm aware of the recording. Harden: Thank you. You were born on July 26th, 1937, the younger son in your family. Would you describe your childhood and your education through high school, especially noting anyone or any experience that helped direct you towards a career in research? Moss: I was born in Brooklyn, New York. My family was a close one. My grandparents lived in the same apartment building and my uncles and aunts lived within walking distance. I attended a public elementary school, which was just across the street. I recall that I was more interested in outside activities and sports. I liked to read, but I didn't particularly want to read what the teachers prescribed. I remember that getting a library card was exciting. I was able to walk to the library and pick out books myself. Despite the fact that I was not terribly interested in the classroom, I scored high in testing. For that reason, I went through a gifted program, called the SP system in New York City.
    [Show full text]
  • Topological Analysis and Functional Characterization of Vaccinia Virus Morphogenesis Proteins
    ABSTRACT Title of Dissertation: TOPOLOGICAL ANALYSIS AND FUNCTIONAL CHARACTERIZATION OF VACCINIA VIRUS MORPHOGENESIS PROTEINS Seong-In Hyun, Doctor of Philosophy, 2017 Dissertation directed by: Dr. Bernard Moss, Adjunct Professor, National Institutes of Health and Dr. Jeffrey DeStefano, Professor, Department of Cell Biology and Molecular Genetics Poxviruses are large, enveloped, double-stranded DNA viruses that replicate in the cytoplasm of host cells and are responsible for diseases of humans and other animals. Vaccinia virus (VACV), the most extensively studied member in the family, encodes approximately 200 proteins, of which 100 are conserved in all members of the vertebrate subfamily of poxviruses and have roles in gene expression, DNA replication, morphogenesis and cell entry. Previous studies have shown that several vaccinia virus proteins localize to the endoplasmic reticulum (ER), suggesting that it serves as the source of viral membranes. Determining the topology of these viral proteins can provide information about protein function and viral membrane formation. My first project involved using an asymmetric self-associating split-GFP system to determine the topology of the transmembrane viral proteins L2 and A30.5 that localize in the endoplasmic reticulum. This split-GFP system uses large (215 aa) and small (16 aa) fragments of GFP that fluoresce only upon complementation. Our results showed that a short GFP fragment can be used to tag small transmembrane viral proteins to determine their localization and topology in vivo. The second project focuses on a protein called I2, which I showed is required for later stage virion morphogenesis. I deleted the I2 gene from the VACV genome by homologous recombination.
    [Show full text]
  • Defective Interfering Particles of Poliovirus I
    JOURNAL OF VIROLOGY, Apr. 1971, p. 478-485 Vol. 7, No. 4 Copyright © 1971 American Society for Microbiology Printed int U.S.A. Defective Interfering Particles of Poliovirus I. Isolation and Physical Properties CHARLES N. COLE, DONNA SMOLER, ECKARD WIMMER, AND DAVID BALTIMORE Departmenit of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 Received for publication 8 January 1971 A class of defective interfering (DI) poliovirus particles has been identified. The first was found as a contaminant of a viral stock; others have been isolated by serial passage at a high multiplicity of infection. The DI particles are less dense than standard virus and sediment more slowly. Their ribonucleic acid (RNA) sediments more slowly than standard RNA and has a higher electrophoretic mobility. Compe- tition hybridization experiments with double-stranded viral RNA indicate that DI RNA is 80 to 90'- of the length of standard RNA. The proteins of DI particles are indistinguishable from those of standard poliovirus. Defective interfering (DI) particles are found (ii) virus diluted serially in medium; (iii) HeLa cells in stocks of many different types of viruses (9). washed twice with medium and resuspended at 107/ml These particles are a natural form of mutant in medium plus 1 horse serum. A mixture of 0.2 which could be useful in the study of viral multi- ml of a given virus dilution with 0.6 ml of cells and 0.6 ml of agar were spread rapidly over base layer plication. They are also of interest because of plates at room temperature, and plates were incu- their possible role in viral disease processes (9).
    [Show full text]